# LY3214996 +/- HCQ in Pancreatic Cancer

> **NCT04386057** · PHASE2 · COMPLETED · sponsor: **Kimberly Perez, MD** · enrollment: 52 (actual)

## Conditions studied

- Pancreatic Cancer
- Advanced Cancer

## Interventions

- **DRUG:** Hydroxychloroquine Sulfate
- **DRUG:** LY3214996

## Key facts

- **NCT ID:** NCT04386057
- **Lead sponsor:** Kimberly Perez, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-27
- **Primary completion:** 2023-08-09
- **Final completion:** 2024-02-05
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386057, "LY3214996 +/- HCQ in Pancreatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04386057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*